UPDATE: Credit Suisse Downgrades Emerson (EMR) to Neutral

Go back to UPDATE: Credit Suisse Downgrades Emerson (EMR) to Neutral

Buckingham Research Downgrades Emerson (EMR) to Underperform

August 19, 2016 8:03 AM EDT

Buckingham Research downgraded Emerson (NYSE: EMR) from Neutral to Underperform with a price target of $44.00.

For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.

Shares of Emerson closed at $54.67 yesterday.

... More

Emerson Electric (EMR) to Acquire Pentair's (PNR) Valves & Controls Business in $3.15B Deal

August 18, 2016 4:31 PM EDT

Emerson (NYSE: EMR) announced it has signed an agreement to purchase the Valves & Controls business of Pentair (NYSE: PNR) for $3.15 billion. The complementary acquisition establishes Emerson's global presence in control, isolation, pressure relief valves and actuation as part of a larger strategy to build a broader automation portfolio.

This acquisition delivers on our strategic plan of investing in Automation Solutions and in markets where we have a global leadership position and see significant long-term growth opportunities, said Chairman and Chief Executive Officer David N. Farr. By adding Pentairs Valves &... More